Histone Deacetylase: A Target for Antiproliferative and Antiprotozoal Agents

E-ISSN： 1875-533x|8|2|211-235

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.8, Iss.2, 2001-02, pp. : 211-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylase inhibitors: from target to clinical trials

By Kelly William K O’Connor Owen A Marks Paul A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. : 1695-1713

Informa Healthcare

Access to resources Recommend Favorite

Histone deacetylase inhibitors: discovery and development as anticancer agents

By Marks Paul A Dokmanovic Milos

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1497-1511

Informa Healthcare

Access to resources Recommend Favorite

Histone deacetylase inhibitors: novel anticancer agents

By Saunders N.A. Popa C. Serewko M.M. Jones S.J. Dicker A.J. Dahler A.L.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1611-1621

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Potent Anti-Leukemic Agents

Current Medicinal Chemistry, Vol. 22, Iss. 17, 2015-06 ,pp. : 2065-2074

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Histone Deacetylase as New Anticancer Agents

Current Medicinal Chemistry, Vol. 8, Iss. 12, 2001-10 ,pp. : 1505-1511

Bentham Science Publishers

Access to resources Recommend Favorite